Related references
Note: Only part of the references are listed.Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Ryan S. Thwaites et al.
SCIENCE IMMUNOLOGY (2021)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan et al.
LANCET RESPIRATORY MEDICINE (2021)
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes et al.
RMD OPEN (2021)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Pulmonary embolism in patients with COVID-19 pneumonia
Florian Bompard et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
Mirko Scarsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takehiro Takahashi et al.
NATURE (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Interleukin-6 in Covid-19: A systematic review andmeta-analysis
Eric A. Coomes et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Colchicine reduces lung injury in experimental acute respiratory distress syndrome
Jocelyn Dupuis et al.
PLOS ONE (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Treating the host response: an alternative way to manage Ebola in Africa and the next influenza pandemic
David S. Fedson
JOURNAL OF GLOBAL HEALTH (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability
Rami Abu-Fanne et al.
BLOOD (2019)
Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects
Binita Shah et al.
INFLAMMATION (2016)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
Jose L. Nieto-Torres et al.
VIROLOGY (2015)
The role of interleukin-1 and the inflammasome in gout - Implications for therapy
Richard M. Pope et al.
ARTHRITIS AND RHEUMATISM (2007)
Colchicine in addition to conventional therapy for acute pericarditis - Results of the colchicine for acute pericarditis (COPE) trial
M Imazio et al.
CIRCULATION (2005)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
Share Paper
